Invitation to webcast in conjunction with Mr Green & Co’s Q1 interim report

On Friday 27 April, at 10:00 a.m. CET a presentation of Mr Green & Co’s first quarter report 2018, will be webcasted. CEO Per Norman and CFO Simon Falk will present the results, followed by a Q&A session. The presentation will be in English and webcasted live through mrg.se  or   http://www.investis-live.com/mr-green/5ab244df80a67515000a73e0/msmm. For phone access, please callFrom Sweden 010 884 80 16 From UK 020 3936 2999 From all other locations +44 20 3936 2999 The access code is 26 36 09. Make sure you are connected to the conference call by

Notice to Annual General Meeting in SSM Holding AB (publ)

The shareholders in SSM Holding AB (publ), 556533-3902 (”SSM” or the ”Company”), are hereby summoned to the Annual General Meeting on Tuesday May 15, 2018 at 13.00 (CET) (the “Meeting”) at Scandic Anglais, Humlegårdsgatan 23, SE-102 44 Stockholm. An easier lunch is served from 12.15 (CET).NOTICE OF ATTENDANCE, ETC. Shareholders who wish to attend at the Meeting must be registered in the share register maintained by Euroclear Sweden AB on Tuesday May 8, 2018, and give notice of attendance to the Company by telephone to +46 (0)771-24 64 00 or by mail to Computershare AB, Attn: SSM Holding

Exercise period of Brighter Warrants TO3, April 11-25.

As part of our financing strategy and the agreement with L1 Capital, Brighter has distributed free warrants to the company's shareholders to reduce dilution. During the period of April 11 to April 25, 2018, holders of TO3 Warrants can exercise the Warrants and subscribe for new shares. One (1) TO3 warrant can be exchanged for one (1) share, at a price of SEK 4.00. Holders of warrants TO3 who have their Warrants registered in custody at a bank or fund commissioner shall contact their bank or fund commissioner, e.g. Avanza (+46-8-562 250 00) or Nordnet (+46-8-806 330 00), if they want

SKF’s first quarter results to be published on 26 April 2018

Gothenburg, 11 April 2018: The SKF Group’s results for the first quarter will be published around 8:00 (CEST) on 26 April 2018. Investors, analysts and media are invited to join a conference call, which will be held in English, at 9:00 (CEST). To join the conference call, please dial-in at least 10 minutes before the start of the call:SE: +46 8 5065 3942UK: +44 330 336 9411US: +1 323 994 2083 Please inform the operator that you with to take part in the SKF conference call. All information regarding the results will be made available on the Group’s website: http://investors.

Atea honored to participate in Global Child Forum

Atea ASA was today granted the honor of participating in the Global Child Forum, a non-profit organization founded by King Carl XVI Gustaf and Queen Silvia of Sweden. This forum was started in 2009 to advance the rights of children in accordance with the UN Convention on the Rights of the Child. The Global Child Forum event will be hosted by their Majesties the King and Queen of Sweden at The Royal Palace, Stockholm, on Wednesday, 11 April 2018 from 9:00AM to 6:00PM. The event is invitation-only but will be Livestreamed starting at 9am CET at www.globalchildforum.org Atea is one of a

H2Station® achieves UL certification as the First Hydrogen Fueling Station Product in the World

(Oslo, 11 April 2018) H2Station® from Nel Hydrogen has successfully achieved the world’s first UL system certification of a hydrogen fuel dispensing system station. The certification sets the new industrial norm and benchmark for safety level and legal compliance for hydrogen fueling stations, and enables a faster and more streamlined installation and permitting process in the United States. The hydrogen fuel dispensing system having achieved UL certification is designed and manufactured in accordance with all the applicable standards for safety. UL certification, carried out by a

Notice of Annual General Meeting in Promore Pharma AB (publ)

Promore Pharma AB (publ) calls for Annual General Meeting which will be held on Wednesday, 16 May 2018 at 3pm, at Wenner-Gren Center, Biblioteket, plan 24, Sveavägen 166, in Stockholm. Registration begins at 2pm.RIGHT TO ATTEND AND NOTIFICATION OF THE COMPANY Anyone wishing to attend the meeting must (i)        be entered as a shareholder in the share register kept by Euroclear Sweden AB as of Wednesday, 9 May 2018, and (ii)       give notice to the Company of its intention to attend no later than Wednesday, 9 May 2018. Notification of attendance may be given in writing to the

Invitation to a telephone conference regarding Trelleborg’s interim report on April 25

Trelleborg’s interim report for the first quarter 2018 will be published on Wednesday April 25 at about 13:00 CET. Analysts, investors and media are invited to attend a telephone conference which will be held at 15:00 CET on the same day. Trelleborg will be represented by President and CEO Peter Nilsson and CFO Ulf Berghult. The telephone conference will begin with a brief presentation of the report, after which participants will be given the opportunity to pose questions. The telephone conference will also be streamed in real-time on the Internet. Visit our website: www.trelleborg.

Strong progress in transforming Fazer into a modern sustainable food company

Like the world around us, Fazer is also continuously transforming. 2017 was a year of renewal and innovation for Fazer. We have now published our Annual Review 2017 on fazergroup.com/annualreview  We have defined a new strategy for 2018–2022. Our focus for the coming years is on value creation through portfolio choices, growth, continued operational excellence and structural improvements. Our ambition is to reach an annual net sales growth of 6-8 per cent and a Group EBITDA level of at least 12 per cent. We will be a

Eltel Norway selects IFS Field Service Management and Accenture to improve the efficiency of 500+ service technicians

Eltel Norway to strengthen market leadership and improve customer satisfaction with IFS Field Service Management IFS , the global enterprise applications company, announces that Eltel Norway  has chosen IFS Field Service Management™  (IFS FSM) and Accenture to help strengthen its position as the leading provider of technical services for critical infrastructure networks for power and communications in the Nordics, Poland,

Announcement of the NAV of Proventus Capital Partners III

The information provided is such that Proventus Capital Partners III AB (publ) is obligated to disclose pursuant to the Securities Markets Act (SFS 2007:528) and/or the Financial Instruments Trading Act (SFS 1991:980). The information was submitted for publication at 09.00 a.m on 11 April 2018.Today the Net Asset Value of the Proventus Capital Partners III participation loans is being announced. At the close of business on 10 April, the Net Asset Value of the series A participation loan debentures amounted to SEK 774,062 each, and the Net Asset Value of the series B participation loan

Viking Grace transforms into a sailing ship on 12 April

Viking Line starts collaboration with the winds of the Baltic Sea. The M/S Viking Grace is the first passenger ship in the world equipped with a rotor sail for the utilisation of wind power. Developed by theFinnish company Norsepower Oy Ltd, the Rotor Sail Solution will cut fuel consumption and reduce emissions by up to 900 tonnes annually. Viking Line will operate the Viking Grace on wind-assisted voyagesbetween Turku (Finland) and Stockholm (Sweden) from April 12th 2018.The cylindrical rotor sail installed on M/S Viking Grace is 24 m in height and 4 m in diameter and it uses the

Publishing of Caverion Corporation's Interim Report for January-March 2018 on 24 April 2018

Caverion Corporation Investor News 11 April 2018 at 10.00 a.m. EESTPublishing of Caverion Corporation's Interim Report for January-March 2018 on 24 April 2018 Caverion Corporation's Interim Report for January-March 2018 will be published on Tuesday, 24 April 2018, at approximately 8:00 a.m. (Finnish Time, EEST). The stock exchange release and presentation materials in Finnish and in English will be published at that time on the company's website at www.caverion.com/investors. News conference for investors and media  Caverion will hold a news conference on the Interim Report on

Kineret® (anakinra) approved in the EU for the treatment of Still’s disease

Swedish Orphan Biovitrum AB (publ)  (Sobi™) announces that the European Commission (EC) has approved an extension of the indication for Kineret (anakinra) to include the treatment of Still’s disease, including Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still’s Disease (AOSD), in all 28 European Union (EU) member states. Still’s disease is a rare systemic multi-organ disorder of auto-inflammatory nature that affects approximately 25,000[1] 

Tradedoubler announces initial results in its ongoing tender offer and written procedure

Reference is made to TradeDoubler Aktiebolag (publ)’s (“Tradedoubler” or the “Company”) ongoing tender offer (the “Tender Offer”) and procedure in writing (the “Written Procedure”) in relation to the Company’s bonds 2013/2018 with an aggregate amount outstanding of SEK 250,000,000 (the “Bonds”), both as announced on 26 March 2018. Tradedoubler today announces that, as of the time for this press release, holders representing approximately 95 per cent of the Adjusted Nominal Amount (as defined in the terms and conditions of the Bonds) of the Bonds have tendered their Bonds in the Tender

NOTICE OF ANNUAL GENERAL MEETING OF SENZAGEN AB

The shareholders of SenzaGen AB, reg. no. 556821-9207, (the “Company”) are hereby summoned to the annual general meeting on Tuesday 8 May 2018 at 19.00 in BioForum at Medicon Village, building 406, Scheelevägen 2 in Lund.Right to attend the general meeting and notification Shareholders who wish to attend the annual general meeting must be included in the share register maintained by Euroclear Sweden AB as of Tuesday May 2 2018. Shareholders shall also notify the Company of their participation and any assistants (no more than two) in the annual general meeting no later than Wednesday 2

Enzymatica AB: New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus

Press Release April 11, 2018 New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus Today Enzymatica announced the results of an in vitro study demonstrating the ability of ColdZyme® Mouth Spray to deactivate human corona virus - one of the most common cold virus families. Along with the in vitro results from a study published in the autumn of 2017[1], ColdZyme has been shown to be able to deactivate over 90 % of the known viruses that cause colds. The current results, which are being presented today at Ear-Nose-and-Throat days in Linköping[2], show

Stefansson et al, ColdZyme forms a protective barrier in the throat that deactivates five major common cold viruses, Congress of the Swedish Association of Otolaryngology, 2018_Abstract

Stefansson et al, ColdZyme forms a protective barrier in the throat that deactivates five major common cold viruses, Congress of the Swedish Association of Otolaryngology, 2018_Poster

ChromoGenics receives a first reference order from Vasakronan

ChromoGenics AB (publ) receives a first reference order from Vasakronan, Sweden's largest real estate company. The order includes approximately 25 sqm dynamic glass to an office building in central Uppsala. Delivery will take place during the second quarter of 2018.The order is a retrofit project where existing windows will be upgraded with ConverLight® glass laminates in Vasakronan's office building on Dragarbrunnsgatan in central Uppsala. At the top floor of the property, the tenant GeoSigma has a number of conference rooms and offices. In these rooms, a total of approximately 25 sqm

Hoist Finance hållbarhetsarbete samt bolagets erbjudande till bankmarknaden i fokus för årsredovisningen 2017

Hoist Finance AB (publ) har idag offentliggjort årsredovisningen för 2017 på bolagets hemsida, www.hoistfinance.com. Fokus har varit att beskriva Hoist Finance erbjudande till den europeiska bankmarknaden samt bolagets arbete med hållbart företagande. Ett särskilt avsnitt ägnas åt den italienska marknaden, som bedöms vara fortsatt mycket intressant. Tryckta kopior av årsredovisningen kan beställas genom att maila till info@hoistfinance.com  Denna information är sådan information som Hoist Finance AB (publ) är skyldigt att offentliggöra enligt lagen om värdepappersmarknaden.

Probi enters the bone health area - a new area for probiotics

Another successful clinical trial on Probi’s probiotic strains has been completed. The results are significant, showing evidence for the development of a new probiotic concept within the area of bone health and osteoporosis  –  a new probiotic area and a completely new health indication for Probi. The randomised, double-blind, placebo-controlled trial included 250 post-menopausal women. The results provide evidence that bone loss is significantly reduced with Probi’s probiotic supplement. The product tested in the study contains a unique combination of three patent protected

The Annual Report for Hoist Finance 2017 is focusing on the company’s sustainability work and its offering to the banking market

Today Hoist Finance released its Annual Report for 2017. Focus has been the company’s sustainability work and its offering to the European banking industry. A section of the report is devoted to the Italian market, one of the most dynamic and interesting markets in Europe.  Printed copies of the Annual Report can be ordered by sending an email to info@hoistfinance.com.  This information is information that Hoist Finance AB (publ) is obliged to make public pursuant to the Securities Markets Act (Sw: lagen om värdepappersmarknaden). The information was submitted, by the below contact

Skanska builds medical school facility in Tampa, Florida, USA, for USD 63M, about SEK 510M

Skanska has signed a contract with the University of South Florida Board of Trustees to build the Morsani College of Medicine and Heart Institute at the University of South Florida campus in Tampa, Florida, USA. The contract is worth USD 63M, about SEK 510M, which will be included in the US order bookings for the first quarter 2018.The contract consists of the construction of about a 37,000-square-meter facility, including auditorium and classroom space, clinic areas and scientific laboratories. Site work began in August 2017, and the project is expected to be complete in Fall/Winter